B
Barry M. Shmookler
Researcher at MedStar Washington Hospital Center
Publications - 39
Citations - 8566
Barry M. Shmookler is an academic researcher from MedStar Washington Hospital Center. The author has contributed to research in topics: Pseudomyxoma peritonei & Thyroglobulin. The author has an hindex of 28, co-authored 39 publications receiving 8159 citations. Previous affiliations of Barry M. Shmookler include Helsinki University Central Hospital & Armed Forces Institute of Pathology.
Papers
More filters
Journal ArticleDOI
Diagnosis of gastrointestinal stromal tumors: A consensus approach.
Christopher D.M. Fletcher,Jules J. Berman,Christopher L. Corless,Fred Gorstein,Jerzy Lasota,B. Jack Longley,Markku Miettinen,Timothy J. O'Leary,Helen Remotti,Brian P. Rubin,Barry M. Shmookler,Leslie H. Sobin,Sharon W. Weiss +12 more
TL;DR: Key elements of the consensus are the defining role of KIT immunopositivity in diagnosis and a proposed scheme for estimating metastatic risk in these lesions, based on tumor size and mitotic count, recognizing that it is probably unwise to use the definitive term "benign" for any GIST, at least at the present time.
Journal ArticleDOI
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".
Brigite M. Ronnett,Christopher M Zahn,Robert J. Kurman,Mary E. Kass,Paul H. Sugarbaker,Barry M. Shmookler +5 more
TL;DR: The term DPAM should be used to diagnose the histologically benign peritoneal lesions associated with ruptured appendiceal mucinous adenomas and those that are pathologically identical but lack a demonstrable appendicesal adenoma, which should be designated PMCA because they have recognizably different pathologic features and a significantly worse prognosis.
Journal Article
Pseudomyxoma peritonei syndrome.
Paul H. Sugarbaker,Brigitte M. Ronnett,Ann G. Archer,Andrew M. Averbach,R Bland,David W. Chang,R R Dalton,S E Ettinghausen,Jacquet P,James S. Jelinek,Koslowe P,R J Kurman,Barry M. Shmookler,Arvil D. Stephens,M A Steves,O.A. Stuart,Susan K. White,C M Zahn,Frans A. N. Zoetmulder +18 more
Journal ArticleDOI
Diagnosis of Gastrointestinal Stromal Tumors:A Consensus Approach
Christopher D.M. Fletcher,Jules J. Berman,Christopher L. Corless,Fred Gorstein,Jerzy Lasota,B. Jack Longley,Markku Miettinen,Timothy J. O'Leary,Helen Remotti,Brian P. Rubin,Barry M. Shmookler,Leslie H. Sobin,Sharon W. Weiss +12 more
TL;DR: Key elements of the consensus are the defining role of KIT immunopositivity indiagnosis and a proposed scheme for estimating metastatic risk in these lesions, based on tumor size and mitotic count, recognizing that it is probably unwise to use the definitive term benign for any GIST, at least at the present time.
Journal ArticleDOI
Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.
TL;DR: A recent study reported a pathologic classification that separated patients into prognostically distinct groups, but the follow-up was relatively short.